Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

65.51
+1.101.71%
Pre-market: 65.580.0700+0.11%09:03 EDT
Volume:2.20M
Turnover:143.82M
Market Cap:12.66B
PE:172.86
High:65.59
Open:64.41
Low:63.57
Close:64.41
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:1.13
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.00
PE(LYR):36.39

Loading ...

Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Major Issues Report

8-K - Current report
May 01, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

Major Issues Report

8-K - Current report
Apr 22, 2020

Major Issues Report

8-K - Current report
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, item 5.02
Nov 04, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Oct 29, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 23, 2019

Major Issues Report

Current report, items 2.02 and 9.01